These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 16553526

  • 1. Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis.
    Mosholder AD, Willy M.
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):25-32. PubMed ID: 16553526
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants.
    Posner K, Oquendo MA, Gould M, Stanley B, Davies M.
    Am J Psychiatry; 2007 Jul; 164(7):1035-43. PubMed ID: 17606655
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetine.
    Apter A, Lipschitz A, Fong R, Carpenter DJ, Krulewicz S, Davies JT, Wilkinson C, Perera P, Metz A.
    J Child Adolesc Psychopharmacol; 2006 Jul; 16(1-2):77-90. PubMed ID: 16553530
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Suicidality in pediatric patients treated with antidepressant drugs.
    Hammad TA, Laughren T, Racoosin J.
    Arch Gen Psychiatry; 2006 Mar; 63(3):332-9. PubMed ID: 16520440
    [Abstract] [Full Text] [Related]

  • 8. Postmarketing surveillance of suicidal adverse events with pediatric use of antidepressants.
    Mosholder AD, Pamer CA.
    J Child Adolesc Psychopharmacol; 2006 Mar; 16(1-2):33-6. PubMed ID: 16553527
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The current crisis of confidence in antidepressants.
    Nierenberg AA, Leon A, Price LH, Shelton RC, Trivedi MH.
    J Clin Psychiatry; 2011 Jan; 72(1):27-33. PubMed ID: 21272514
    [No Abstract] [Full Text] [Related]

  • 14. Retrospective analysis of suicidality in patients treated with the antidepressant desvenlafaxine.
    Tourian KA, Padmanabhan K, Groark J, Ninan PT.
    J Clin Psychopharmacol; 2010 Aug; 30(4):411-6. PubMed ID: 20631558
    [Abstract] [Full Text] [Related]

  • 15. Antidepressants use in children and adolescents and the risk of suicide.
    Wohlfarth TD, van Zwieten BJ, Lekkerkerker FJ, Gispen-de Wied CC, Ruis JR, Elferink AJ, Storosum JG.
    Eur Neuropsychopharmacol; 2006 Feb; 16(2):79-83. PubMed ID: 16298514
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression.
    Tollefson GD, Rampey AH, Beasley CM, Enas GG, Potvin JH.
    J Clin Psychopharmacol; 1994 Jun; 14(3):163-9. PubMed ID: 8027412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.